MATTHEW C RALSTIN M.D.
Prescription History 1104088731
Ophthalmology in Warsaw, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MATTHEW C RALSTIN M.D., an active Ophthalmology specialist practicing in Warsaw, IN. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,128 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 285 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Prednisolone Acetate | 285 | $50.24 | ▲ More than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 285 Medicare prescriptions for Prednisolone Acetate, about 3.3 times the volume of the typical Indiana prescriber of this medication (87). Medicare paid an average of $50.24 per fill, versus $49.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 405.9 30-Day Fills standardized to 30-day supplies 11,775 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 278 | $23.97 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 278 Medicare prescriptions for Latanoprost, about 2.3 times the volume of the typical Indiana prescriber of this medication (121). Medicare paid an average of $23.97 per fill, versus $23.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 538.7 30-Day Fills standardized to 30-day supplies 15,626 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 213 | $30.16▼ below IN avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 213 Medicare prescriptions for Dorzolamide-Timolol, about 3.2 times the volume of the typical Indiana prescriber of this medication (66). Medicare paid an average of $30.16 per fill, versus $32.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 451.9 30-Day Fills standardized to 30-day supplies 13,549 Days of Medication total across all patients in 2023 | |||
| Diclofenac Sodium | 131 | $10.75▼ below IN avg | ▲ More than typical |
About Diclofenac Sodium: See also Warning section. Show more ▾ This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. In 2023, this provider wrote 131 Medicare prescriptions for Diclofenac Sodium, about 3.3 times the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $10.75 per fill, versus $32.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 138.5 30-Day Fills standardized to 30-day supplies 3,596 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 82 | $13.98▼ below IN avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 82 Medicare prescriptions for Timolol Maleate, about 7.5 times the volume of the typical Indiana prescriber of this medication (11). Medicare paid an average of $13.98 per fill, versus $561.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 163.7 30-Day Fills standardized to 30-day supplies 4,807 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 49 | $25.60▼ below IN avg | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 49 Medicare prescriptions for Brimonidine Tartrate, about the same volume as the typical Indiana prescriber of this medication (50). Medicare paid an average of $25.60 per fill, versus $40.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 121.3 30-Day Fills standardized to 30-day supplies 3,608 Days of Medication total across all patients in 2023 | |||
| BromsiteBromfenac Sodium | 19 | $290.45 | ≈ Typical |
About Bromsite: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 19 Medicare prescriptions for Bromsite, about 83% of the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $290.45 per fill, versus $289.26 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.3 30-Day Fills standardized to 30-day supplies 959 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 13 | $13.54▼ below IN avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical Indiana prescriber of this medication (45). Medicare paid an average of $13.54 per fill, versus $30.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 18.4 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 12 | $23.95 | ▼ Less than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 12 Medicare prescriptions for Acyclovir, about half the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $23.95 per fill, versus $23.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 12 | $456.98▼ below IN avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 12 Medicare prescriptions for Lumigan, about a quarter of the volume of the typical Indiana prescriber of this medication (52). Medicare paid an average of $456.98 per fill, versus $479.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 20.2 30-Day Fills standardized to 30-day supplies 578 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $646.97 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 12 Medicare prescriptions for Rocklatan, about a third of the volume of the typical Indiana prescriber of this medication (32). Medicare paid an average of $646.97 per fill, versus $530.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 11 | $10.68▼ below IN avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 11 Medicare prescriptions for Erythromycin, about a quarter of the volume of the typical Indiana prescriber of this medication (40). Medicare paid an average of $10.68 per fill, versus $26.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 11 30-Day Fills standardized to 30-day supplies 162 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 11 | $42.60 | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 11 Medicare prescriptions for Moxifloxacin, about 17% of the volume of the typical Indiana prescriber of this medication (64). Medicare paid an average of $42.60 per fill, versus $34.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 175 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MATTHEW C RALSTIN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Warsaw, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
